Does RITUXIMAB Cause Multiple sclerosis relapse? 286 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 286 reports of Multiple sclerosis relapse have been filed in association with RITUXIMAB (Rituxan). This represents 0.2% of all adverse event reports for RITUXIMAB.
286
Reports of Multiple sclerosis relapse with RITUXIMAB
0.2%
of all RITUXIMAB reports
3
Deaths
69
Hospitalizations
How Dangerous Is Multiple sclerosis relapse From RITUXIMAB?
Of the 286 reports, 3 (1.0%) resulted in death, 69 (24.1%) required hospitalization, and 3 (1.0%) were considered life-threatening.
Is Multiple sclerosis relapse Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 286 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Multiple sclerosis relapse?
DIMETHYL (6,852)
FINGOLIMOD (6,728)
NATALIZUMAB (6,478)
INTERFERON BETA-1A (5,931)
TERIFLUNOMIDE (4,745)
GLATIRAMER (3,695)
DALFAMPRIDINE (3,322)
OCRELIZUMAB (2,326)
OFATUMUMAB (1,525)
INTERFERON BETA-1B (1,229)
Which RITUXIMAB Alternatives Have Lower Multiple sclerosis relapse Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE